Cargando…
Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India?
This study examines how Chinese drug regulations are shifting illicit fentanyl production from China to India. This change has implications for the law, drug enforcement, pharmaceutical industry, and public health, as domestic production increases domestic access to fentanyl, in India. An empirical...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614337/ https://www.ncbi.nlm.nih.gov/pubmed/36311594 http://dx.doi.org/10.3389/fpubh.2022.969395 |
_version_ | 1784820178745294848 |
---|---|
author | Wang, Chao Lassi, Nicholas |
author_facet | Wang, Chao Lassi, Nicholas |
author_sort | Wang, Chao |
collection | PubMed |
description | This study examines how Chinese drug regulations are shifting illicit fentanyl production from China to India. This change has implications for the law, drug enforcement, pharmaceutical industry, and public health, as domestic production increases domestic access to fentanyl, in India. An empirical examination of current trends in fentanyl production and use in the region is conducted, along with an exegesis of the legal and regulatory systems in China and India. There is an accounting of the chemical and pharmaceutical industries, the strengths and weaknesses of drug legislation, and the public health consequences of increased production, distribution, and use of fentanyl in India. This study also details how the Indian government meets this challenge through legislative mechanisms, foremost through class-wide legislative control over fentanyl and its precursors. Class-wide control prohibits the unlawful production and distribution of all current and future fentanyl analogs and their precursors, disincentivizing and disrupting their development and production. The Indian government should also reduce domestic demand by promoting harm reduction measures such as opioid substitution therapy, evidence-based treatment, fentanyl test strip and naloxone distribution, and needle exchange programs. |
format | Online Article Text |
id | pubmed-9614337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96143372022-10-29 Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? Wang, Chao Lassi, Nicholas Front Public Health Public Health This study examines how Chinese drug regulations are shifting illicit fentanyl production from China to India. This change has implications for the law, drug enforcement, pharmaceutical industry, and public health, as domestic production increases domestic access to fentanyl, in India. An empirical examination of current trends in fentanyl production and use in the region is conducted, along with an exegesis of the legal and regulatory systems in China and India. There is an accounting of the chemical and pharmaceutical industries, the strengths and weaknesses of drug legislation, and the public health consequences of increased production, distribution, and use of fentanyl in India. This study also details how the Indian government meets this challenge through legislative mechanisms, foremost through class-wide legislative control over fentanyl and its precursors. Class-wide control prohibits the unlawful production and distribution of all current and future fentanyl analogs and their precursors, disincentivizing and disrupting their development and production. The Indian government should also reduce domestic demand by promoting harm reduction measures such as opioid substitution therapy, evidence-based treatment, fentanyl test strip and naloxone distribution, and needle exchange programs. Frontiers Media S.A. 2022-10-14 /pmc/articles/PMC9614337/ /pubmed/36311594 http://dx.doi.org/10.3389/fpubh.2022.969395 Text en Copyright © 2022 Wang and Lassi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Wang, Chao Lassi, Nicholas Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? |
title | Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? |
title_full | Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? |
title_fullStr | Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? |
title_full_unstemmed | Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? |
title_short | Combating illicit fentanyl: Will increased Chinese regulation generate a public health crisis in India? |
title_sort | combating illicit fentanyl: will increased chinese regulation generate a public health crisis in india? |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614337/ https://www.ncbi.nlm.nih.gov/pubmed/36311594 http://dx.doi.org/10.3389/fpubh.2022.969395 |
work_keys_str_mv | AT wangchao combatingillicitfentanylwillincreasedchineseregulationgenerateapublichealthcrisisinindia AT lassinicholas combatingillicitfentanylwillincreasedchineseregulationgenerateapublichealthcrisisinindia |